Karnataka: Shivamogga Doctor Dies; Govt Says Not Linked To Vaccine

BENGALURU : A 58-year-old doctor from Shivamogga died on Wednesday, two days after he was given Covishield vaccine. The Union health ministry’s report on Adverse Effects Following Immunisation said the death was due to cardiac problems. District health officer Rajesh Suragihalli said the death of Dr Jayaprakash TA, who was with Subbaiah medical college hospital, is not linked to the vaccination drive.

He developed severe chest pain in the early hours of Wednesday and was admitted to a private hospital where he died hours later, said Dr SM Katti, principal of the medical college. District health officer Dr Rajesh Suragihalli told TOI: “He died due to cardiac problems. He had been suffering from heart-related issues for some time now. His death is not related to the vaccine drive, which is also confirmed by the Union health ministry. After taking vaccination, he had shared his pictures on social media and requested frontline warriors to come forward.”

Jayaprakash’s wife, a gynaecologist who works in Shivamogga, and two daughters are away in the US. Katti said the doctor suffered a cardiac arrest and the death is not linked to the vaccine.

Pankaj Kumar Pandey, commissioner, health and family welfare department, said the doctor had conducted classes after his vaccination and was doing well after taking the jab. “It is learned that he was highly diabetic and had undergone bypass surgery earlier. The reports say that he has died due to cardiac arrest,” he said.

Related Posts

  • Pharma
  • July 22, 2025
  • 81 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 479 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end